Cat. # | Size | Qty. | Price |
---|---|---|---|
35574T | 1 Kit (8 x 20 microliters) |
|
$ 592 |
Product Includes | Quantity | Applications | Reactivity | MW(kDa) | Isotype |
---|---|---|---|---|---|
NeuN (D4G4O) XP® Rabbit mAb 24307 | 20 µl |
|
H M R | 46-55 | Rabbit IgG |
GAP43 (D9C8) Rabbit mAb 8945 | 20 µl |
|
H M R | 38, 43 | Rabbit IgG |
MAP2 (D5G1) XP® Rabbit mAb 8707 | 20 µl |
|
M R | 75, 82, 280 | Rabbit IgG |
Neurofilament-L (C28E10) Rabbit mAb 2837 | 20 µl |
|
H M R | 70 | Rabbit IgG |
β3-Tubulin (D71G9) XP® Rabbit mAb 5568 | 20 µl |
|
H M R | 55 | Rabbit IgG |
Synaptophysin (D8F6H) XP® Rabbit mAb 36406 | 20 µl |
|
H M R | 38 | Rabbit IgG |
PSD95 (D27E11) XP® Rabbit mAb 3450 | 20 µl |
|
H M R | 95 | Rabbit IgG |
UCHL1 (D3T2E) XP® Rabbit mAb 13179 | 20 µl |
|
H M R Mk | 27 | Rabbit IgG |
Anti-rabbit IgG, HRP-linked Antibody 7074 | 100 µl |
|
Goat |
Product Information
Rabbit monoclonal antibodies are produced by immunizing animals with one of the following antigens: 1) synthetic peptides corresponding to residues surrounding Lys30 of human GAP43 protein, Glu450 of human Neurofilament-L protein, Gly299 of human Synaptophysin protein, or Gln53 of human PSD95 protein, 2) synthetic peptides corresponding to residues near the carboxy terminus of human MAP2 protein, the carboxy terminus of human β3-tubulin protein, or the carboxy terminus of human UCHL1 protein, or 3) recombinant protein specific to the amino terminus of human NeuN protein.
Explore pathways + proteins related to this product.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.